Insight Molecular Diagnostics (IMDX) Other Working Capital Changes (2015 - 2026)
Insight Molecular Diagnostics (IMDX) posted Other Working Capital Changes of -$83000.0 for Q1 2026, down 315.0% sequentially from -$20000.0 in Q4 2025, and down 197.65% YoY from $85000.0 in Q1 2025.
Insight Molecular Diagnostics (IMDX) Other Working Capital Changes (2015 - 2026) Analysis & Trends
Insight Molecular Diagnostics (IMDX) has 12 years of Other Working Capital Changes data on file, last reported at -$83000.0 in Q1 2026.
- Quarterly Other Working Capital Changes fell 197.65% year-over-year to -$83000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$310000.0 (down 15.67% YoY) and the FY2025 annual result came in at -$142000.0, up 51.2% from the prior year.
- Other Working Capital Changes fell to -$83000.0 in Q1 2026 per IMDX's latest filing, from -$20000.0 in the prior quarter.
- The five-year high for Other Working Capital Changes was $795000.0 in Q3 2022, with the low at -$514000.0 in Q4 2022.
- Average Other Working Capital Changes over 5 years is -$24500.0, with a median of -$46000.0 recorded in 2022.
- The widest YoY moves for Other Working Capital Changes: up 1104.55% in 2022, down 2236.36% in 2022.
- Insight Molecular Diagnostics' Other Working Capital Changes stood at -$514000.0 in 2022, then surged by 87.55% to -$64000.0 in 2023, then tumbled by 162.5% to -$168000.0 in 2024, then jumped by 88.1% to -$20000.0 in 2025, then sank by 315.0% to -$83000.0 in 2026.
- Business Quant data shows IMDX's Other Working Capital Changes at -$83000.0 in Q1 2026, -$20000.0 in Q4 2025, and -$57000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn |
| 10 | Insight Molecular Diagnostics | 196.41 Mn | 167.48 Mn | 15,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -83,000.00 |
| Mar 31, 2026 | -83,000.00 |
| Dec 31, 2025 | -20,000.00 |
| Dec 31, 2025 | -20,000.00 |
| Sep 30, 2025 | -57,000.00 |
| Sep 30, 2025 | -57,000.00 |
| Jun 30, 2025 | -150,000.00 |
| Jun 30, 2025 | -150,000.00 |
| Mar 31, 2025 | 85,000.00 |
| Mar 31, 2025 | 85,000.00 |
| Dec 31, 2024 | -168,000.00 |
| Dec 31, 2024 | -168,000.00 |
| Jun 30, 2024 | -185,000.00 |
| Jun 30, 2024 | -185,000.00 |
| Mar 31, 2024 | 62,000.00 |
| Mar 31, 2024 | 62,000.00 |
| Dec 31, 2023 | -64,000.00 |
| Dec 31, 2023 | -64,000.00 |
| Sep 30, 2023 | 75,000.00 |
| Sep 30, 2023 | 75,000.00 |